Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Cellect Biotechnology Ltd (APOP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,841
  • Shares Outstanding, K 5,440
  • Annual Sales, $ 0 K
  • Annual Income, $ -5,370 K
  • 60-Month Beta 2.42
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.28
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.71
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 05/16/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.85 +2.29%
on 04/18/19
1.11 -21.62%
on 03/27/19
-0.12 (-12.24%)
since 03/22/19
3-Month
0.85 +2.29%
on 04/18/19
3.83 -77.28%
on 02/07/19
-1.97 (-69.37%)
since 01/22/19
52-Week
0.85 +2.29%
on 04/18/19
7.80 -88.85%
on 05/31/18
-5.90 (-87.15%)
since 04/20/18

Most Recent Stories

More News
Cellect Announces Positive Phase I/II Mid-Study Results of Its ApoGraft(TM) Technology

Further validating its ApoGraft(TM) technology, Cellect Biotechnology Ltd. (Nasdaq: APOP), a developer of a novel stem cell production technology, announced positive mid-study data from the Company's Phase...

APOP : 0.89 (unch)
Cellect Biotechnology Reports Fourth Quarter and Full Year 2018 Results and Recent Corporate Progress

Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of a novel stem cell production technology, today announced operating and financial results for the fourth quarter and full year ended December 31,...

APOP : 0.89 (unch)
Cellect Announces Positive Results From Cell2in Collaboration Showing Significant Improvement in Expansion Rate and Function of Stem Cells

Cellect Biotechnology Ltd. (Nasdaq: APOP), a developer of a novel stem cell production technology, today announced positive preliminary results from its collaboration with Cell2in, a privately-held South...

APOP : 0.89 (unch)
Cellect Announces Closing of $6.5 Million Underwritten Public Offering

Cellect Biotechnology Ltd. (Nasdaq: APOP), a developer of a novel stem cell production technology, today announced the closing of its previously announced $6.5 million underwritten public offering of 1,889,000...

APOP : 0.89 (unch)
Cellect Announces Pricing of $6.5 Million Public Offering

Cellect Biotechnology Ltd. (Nasdaq: APOP), a developer of a novel stem cell production technology, today announced the pricing of an underwritten public offering of 1,889,000 units, with each unit consisting...

APOP : 0.89 (unch)
Cellect Begins Collaboration with Washington University in Preparation for First U.S. Clinical Trial Using Cellect's ApoGraft(TM) for Bone Marrow Transplantations

Cellect Biotechnology Ltd. (Nasdaq: APOP), a developer of a novel stem cell production technology, today announced a collaboration with Washington University, a leading academic institution based in St....

APOP : 0.89 (unch)
Cellect Biotechnology Reports Clinical and Regulatory Milestone Targets

Cellect Biotechnology Ltd. (Nasdaq: APOP), a novel regenerative and cell therapy company with production technology, today provided its milestone targets through the second quarter of 2020. After achieving...

APOP : 0.89 (unch)
Further to the Announcement of the Agreement Signed With the South Korean Cell2in: KORIL Approves Cellect's Grant Application

Cellect Biotechnology Ltd. (Nasdaq: APOP), a developer of a novel stem cell production technology, announced that KORIL-RDF, has approved Cellect's grant application, submitted with Cell2in, a Korean cell...

APOP : 0.89 (unch)
Cellect Biotechnology Ltd Provides Corporate Update and Reports First Quarter 2018 Financial Results

Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, today provided a corporate update and announced financial results for...

APOP : 0.89 (unch)
Former GE Healthcare Executive to Join Cellect as Chief Business Officer

Cellect Biotechnology Ltd. (Nasdaq: APOP), a developer of a novel stem cell manufacturing technology, announced that it will open a U.S. center of operations to be led by Andrew Sabatier.

APOP : 0.89 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade APOP with:

Business Summary

Cellect Biotechnology Ltd. offers biomedical services. It provides stem cell transplantation, disease management, regenerative medicine, clinical research and other services. Cellect Biotechnology Ltd. is based in TEL AVIV, Israel.

See More

Key Turning Points

2nd Resistance Point 0.95
1st Resistance Point 0.92
Last Price 0.89
1st Support Level 0.85
2nd Support Level 0.82

See More

52-Week High 7.80
Fibonacci 61.8% 5.15
Fibonacci 50% 4.33
Fibonacci 38.2% 3.51
Last Price 0.89
52-Week Low 0.85

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar